Get notified when ENSC files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Board Resignation With No Reason Disclosed (new) — Unexplained director departures can signal internal disagreements or concerns about company direction that investors should monitor.
NASDAQ: ENSC Ensysce Biosciences, Inc. 8-K

Ensysce Biosciences board member Curtis Rosebraugh resigns effective April 1

Filed April 3, 2026 · Period ending April 3, 2026 · ~1 min read

Key Changes

  • medium

    Curtis Rosebraugh resigned from the Board of Directors and Nominating and Corporate Governance Committee effective April 1, 2026. The company did not disclose a reason for his departure.

  • medium

    The resignation reduces board oversight capacity at a time when the small biotech company may need experienced governance, particularly in nominating and corporate governance functions.

    8-K: Board Changes verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (SNOA 10-K) is open in full — no account needed.

Partner

Trade ENSC commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 3, 2026 3:43 PM